Guideline implementation for breast healthcare in low- and middle-income countries: Treatment resource allocation

Cancer

Volumn 113, Issue 8 SUPPL., 2008, Pages 2269-2281

  Eniu, Alexandru ^a   Carlson, Robert W ^b   El Saghir, Nagi S ^c   Bines, Jose ^d   Bese, Nuran Senel ^e   Vorobiof, Daniel ^f   Masetti, Riccardo ^g   Anderson, Benjamin O ^h,i  

^a Cancer Institute Ion Chiricuta Cluj Napoca   (Romania)

^b STANFORD UNIVERSITY   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^e ISTANBUL UNIVERSITY   (Turkey)

^f Sandton Oncology Centre   (South Africa)

^g CATHOLIC UNIVERSITY   (Italy)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast cancer; Limited resources; Locoregional therapy (surgery, radiation therapy); Process metrics; Systemic therapy; Treatment guidelines

Indexed keywords

ANALGESIC AGENT; ANTHRACYCLINE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; FULVESTRANT; GONADORELIN AGONIST; GROWTH FACTOR; LAPATINIB; METHOTREXATE; OPIATE; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ALLERGIC REACTION; ARTHRALGIA; BLEEDING; BONE MARROW DISEASE; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOTOXICITY; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; EYE TOXICITY; FRACTURE; GENE OVEREXPRESSION; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH PROGRAM; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYPERTENSION; MASTECTOMY; METASTASIS; MONOTHERAPY; NEPHROTIC SYNDROME; NEUROLOGIC DISEASE; ONCOGENE NEU; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; RESOURCE ALLOCATION; SOCIAL STATUS; SYSTEMIC THERAPY; THROMBOEMBOLISM; THROMBOSIS; UNSPECIFIED SIDE EFFECT;

BENCHMARKING; BREAST; BREAST NEOPLASMS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HUMANS; PROGRAM EVALUATION; RESOURCE ALLOCATION;

EID: 56449105284     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23843     Document Type: Conference Paper

References (21)

1. Carlson RW, Anderson BO, Burstein HJ, et al. Invasive breast cancer. J Natl Compr Canc Netw. 2007;5:246-312.
2. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133-1144.
3. Pavlidis N, Hansen H, Stahel R. ESMO clinical recommendations: a practical guide for medical oncologists. Ann Oncol. 2007;18:1759-1763.
4. Carlson RW, Anderson BO, Chopra R, et al. Treatment of breast cancer in countries with limited resources. Breast J. 2003;9(suppl 2):S67-S74.
5. Eniu A, Carlson RW, Aziz Z, et al. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J. 2006;12(suppl 1):S38-S53.
6. Anderson BO, Braun S, Carlson RW, et al. Overview of breast health care guidelines for countries with limited resources. Breast J. 2003;9(suppl 2):S42-S50.
7. Smith RA, Caleffi M, Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J. 2006;12(suppl 1):S16-S26.
8. Shyyan R, Masood S, Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006;12(suppl 1):S27-S37.
9. Anderson BO, Yip CH, Ramsey SD, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J. 2006;12(suppl 1):S54-S69.
10. Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006;12(suppl 1):S3-S15.
11. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24:626-634.
12. El Saghir NS, Eniu A, Carlson RW, et al.; for the Breast Health Global Initiative (BHGI) Systemic Therapy Focus Group. Management of locally advanced breast cancer: balancing clinical progress and resources. Cancer. 2008;113 (8 suppl):2315-2324.
13. Bese NS, Budrukkar A, Elzawawy A, et al.; for the Breast Health Global Initiative (BHGI) Radiation Therapy Focus Group. Breast cancer in limited resource countries: implementation and evidence-based recommendations for radiation therapy. Cancer. 2008;113(8 suppl):2305-2314.
14. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087-2106.
15. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687-1717.
16. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-3636.
17. Schwartsmann G. Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol. 2001;19(18 suppl):118S-124S.
18. Vorobiof DA, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol. 2001;19(18 suppl):125S-127S.
19. El Saghir NS, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg. 2007;5:225-233.
20. Rugo HS. The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors. Ann Oncol. 2008;19:16-27.
21. World Health Organization. Executive Summary of the National Cancer Control Programmes: Policies and Managerial Guidelines. Geneva, Switzerland: World Health Organization; 2002.